Search
Tacrolimus
go.drugbank.com/drugs/DB00864ApprovedInvestigationalTacrolimus (also FK-506 or Fujimycin) is an immunosuppressive drug whose main use is after organ transplant to reduce the activity of the patient's immune system and so the risk of organ rejection. … It is also used in a topical preparation in the treatment of severe atopic dermatitis, severe refractory uveitis after bone marrow transplants, and the skin condition vitiligo.
Mixtures: Hyaluronic Acid Sodium Salt 1% / Tacrolimus 0.1% / Urea 20%, Hyaluronic Acid Sodium Salt 1% / Niacinamide 4% / Tacrolimus 0.1%Categories: Agents for Dermatitis, Excluding CorticosteroidsAmphotericin B
go.drugbank.com/drugs/DB00681ApprovedInvestigational1.0 mcg/mL in vitro. … The antibiotic is without effect on bacteria, rickettsiae, and viruses.
Categories: Compounds used in a research, industrial, or household setting, Antimycotics for Systemic UseProducts: AMPHOTRET FOR INJECTION USP 50MG, Amphotericin B for Injection, USPTeicoplanin
go.drugbank.com/drugs/DB06149ApprovedInvestigationalWithdrawnAll teicoplanins share a same glycopeptide core, teicoplanin A3-1, but differ in the length and conformation of side chains attached to their β-D-glucosamine moiety. … Teicoplanin is a glycopeptide antibiotic consisting of a mixture of several compounds, five major (named teicoplanin A2-1 through A2-5) and four minor (named teicoplanin RS-1 through RS-4).
Categories: Antibacterials for Systemic Use, Antiinfectives for Systemic UseProducts: TARGOCID 200mg POWDER FOR SOLUTION FOR INJECTION/INFUSION, Ticplat 200 (Teicoplanin 200mg powder for solution for injection or infusion)Von Willebrand factor human
go.drugbank.com/drugs/DB13133ApprovedInvestigational[L1878] A recombinant form of vWF, [vonicog alfa], is also available to enhance production and avoid the theoretical risk of pathogen transmission from plasma donors.[A32262] … [A32262] Exogenous sources of vWF are used to restore functional levels of vWF in blood disorders associated with deficient or abnormal blood clotting.
Mixtures: OPTIVATE(R), VONCENTO 1000 UI/ 2400 UICategories: von Willebrand factor and coagulation factor VIII in combinationSymptomatic for no more than 48 hours.
go.drugbank.com/conditions/DBCOND0116964Drugs: OseltamivirSynonyms: Symptomatic for no more than 48 hours, Symptomatic for no more than 48 hours.Ganirelix
go.drugbank.com/drugs/DB06785ApprovedInvestigationalGanirelix is indicated for controlled ovarian hyperstimulation in assisted reproduction techniques. … [L43045] The first case of pregnancy achieved after the use of ganirelix in an assisted reproduction program was reported in 1998.[A252195] Ganirelix was first approved by the FDA on July 29, 1999.
Products: ORGALUTRAN SOLUTION FOR INJECTION 0.25 mg/0.5 ml, ORGALUTRAN 0.25MG/0.5ML (SOLUTION FOR INJECTION)Certolizumab pegol
go.drugbank.com/drugs/DB08904ApprovedInvestigational[A176606] It was developed and manufactured by UCB Pharma, first FDA approved in 2008[L45018] and updated for a new indication on March 28, 2019.[L5819] … [A176606] Certolizumab does not require glycosylation for active function and hence, its production is significantly more affordable when compared to other existing TNF-alpha therapies as it can be
Categories: Biologics for Rheumatoid Arthritis TreatmentProducts: CIMZIA 200 MG ILO IN FER, CIMZIA 200MG ILO IN FERSodium acetate
go.drugbank.com/drugs/DB09395ApprovedInvestigationalIt can be used also in metabolic acidosis and for urine alkalinization. … Medically, sodium acetate is important component as an electrolyte replenisher when given intravenously. It is mainly indicated to correct sodium levels in hyponatremic patients.
Mixtures: Isolyte R In 5% Dextrose, OLICLINOMEL N4-550 E EMULSION FOR INFUSIONSynonyms: acetic acid, sodium salt, Acetic acid, sodium salt (1:1)Sevelamer
go.drugbank.com/drugs/DB00658ApprovedInvestigationalSevelamer is a phosphate binding drug used to prevent hyperphosphataemia in patients with chronic renal failure. It is marketed by Genzyme under the trade name Renagel.
Categories: Compounds used in a research, industrial, or household setting, Drugs for Treatment of Hyperkalemia and HyperphosphatemiaProducts: Sevelamer Carbonate for Oral Suspension, Sevelamer Carbonate For Oral SuspensionCarfilzomib
go.drugbank.com/drugs/DB08889ApprovedInvestigationalFDA approved carfilzomib in July 2012 for the treatment of adults with relapsed or refractory multiple myeloma as monotherapy or combination therapy.[L39392] … Carfilzomib is an injectable antineoplastic agent (IV only). Chemically, it is a modified tetrapeptidyl epoxide and an analog of epoxomicin. It is also a selective proteasome inhibitor.
Products: KYPROLIS POWDER FOR SOLUTION FOR INFUSION 60MG/VIAL, KYPROLIS POWDER FOR SOLUTION FOR INFUSION 30 MG/VIAL